Related Experiment Video

Updated: May 31, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

[The IKKε kinase in breast cancer: from oncogenesis to treatment resistance]

Nathalie Grandvaux1

  • 1Chaire de recherche du Canada en signalisation et infections virales, centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Hôpital Saint-Luc, 264, boulevard René Lévesque Est, PEA 311 Montréal (Québec), H2X 1P1, Canada. nathalie.grandvaux@umontreal.ca

Medecine Sciences : M/S
|July 2, 2011
PubMed

Insights

The IKKε kinase is overexpressed in breast cancer and drives oncogenic signaling. Targeting IKKε may overcome Tamoxifen resistance and offer new breast cancer treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The IKKε kinase, an atypical IKK family member, is identified as an oncogene.
  • IKKε is overexpressed in over 30% of breast cancers.
  • IKKε regulates NF-κB and phosphorylates multiple substrates involved in cancer development.

Purpose of the Study:

  • To investigate the role of IKKε in breast cancer oncogenesis.
  • To identify novel IKKε-mediated signaling pathways as therapeutic targets.
  • To explore IKKε's involvement in Tamoxifen resistance.

Main Methods:

  • Analysis of IKKε expression in breast cancer.
  • Phosphorylation site analysis of IKKε substrates.
  • Investigation of IKKε's role in Tamoxifen resistance.

Main Results:

  • IKKε overexpression is prevalent in breast cancer.
  • Phosphorylation of IKKε substrates reveals new oncogenic pathways.
  • IKKε contributes to Tamoxifen resistance in breast cancer.

Conclusions:

  • IKKε is a significant oncogene in breast cancer.
  • Targeting IKKε and its downstream pathways offers potential therapeutic strategies.
  • IKKε inhibition may be a viable approach to overcome Tamoxifen resistance.

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...